Showing results (1-10 of 443) with videos related to
Sort By:
Pageof 45
Future Oncology (London, England)|March 16, 2019
Aldoxorubicin in soft tissue sarcomasFlorence E Chamberlain, Robin L Jones, Sant P ChawlaExpert Opinion on Investigational Drugs|April 24, 2019
Pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaFlorence E Chamberlain, Chris Wilding, Robin L Jones, et al.Investigational New Drugs|November 1, 2013
A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of TumorsRobin L Jones, Stefano Ferrari, Jean Yves Blay, et al.Current Oncology Reports|March 23, 2021
Giant Cell Tumor of Bone: An UpdateAtrayee Basu Mallick, Sant P ChawlaExpert Review of Clinical Pharmacology|August 27, 2013
Ridaforolimus in advanced or metastatic soft tissue and bone sarcomasMonica M Mita, Jun Gong, Sant P ChawlaFuture Oncology (London, England)|February 8, 2018
Eribulin therapy for the treatment of patients with advanced soft tissue sarcomaMahesh Seetharam, Kantha R Kolla, Sant P ChawlaBiologics : Targets & Therapy|July 24, 2015
Giant-cell tumor of bone: treatment options and role of denosumabArun S Singh, Neal S Chawla, Sant P ChawlaAdvances in Therapy|May 29, 2016
Trabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesErlinda M Gordon, K Kumar Sankhala, Neal Chawla, et al.Expert Review of Cardiovascular Therapy|November 21, 2008
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicityRobin L JonesFuture Oncology (London, England)|September 11, 2019
Sarcomas and old age: few options for such a large patient populationRobin L JonesPageof 45